CRDF Earnings

Quarterly EPS
$-0.25
Q3 2024
$-0.22
Q4 2024
$-0.20
Q1 2025
$-0.21
Q2 2025
$-0.17
Q3 2025
$-0.11
Q4 2025
$-0.18
Q1 2026
$-0.14
Q2 2026
Latest Revenue104.0K
Latest Net Income-9232000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.14104.0K-9232000-14.0%+33.3%
Q1 2026-$0.1841.0K-12345000-62.4%+10.0%
Q4 2025-$0.11243.0K-7216000+60.9%+50.0%
Q3 2025-$0.17120.0K-11258000-27.3%+32.0%
Q2 2025-$0.21121.0K-13943000-25.8%+19.2%
Q1 2025-$0.20109.0K-13434000-46.8%+9.1%
Q4 2024-$0.22151.0K-11787000-3.2%-4.8%
Q3 2024-$0.25165.0K-11855000+17.0%-13.6%
Q2 2024-$0.26163.0K-11778000
Q1 2024-$0.22205.0K-10011000
Q4 2023-$0.21156.0K-9337000
Q3 2023-$0.22141.0K-9731000
Cardiff Oncology (CRDF) — Earnings